"Designing Growth Strategies is in our DNA"

Patient-Specific Implants Market Size, Share, and Industry Analysis, By Product (Cranial Implants, Orthopedic Implants, Dental Implants, and Others), By Application (Neurosurgery, Trauma, Dental & Maxillofacial Surgery, Orthopedic Surgery, and Others), By Material (Alloy, Polyetheretherketone (PEEK), Polymethylmethacrylate (PMMA), Poly-ether-ketone-ketone (PEKK), and Others), By End User (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

Region : Global | Report ID: FBI109756 | Status : Ongoing

 

KEY MARKET INSIGHTS

Patient-specific implants are personalized medical devices tailored for individual patients, offering enhanced precision and improved surgery outcomes. These implants are used to improve and facilitate precise implantation, with the overall aim to improve the outcome of key surgical procedures, such as arthroplasty. These custom-made and standard implants are mainly used in ankle arthroplasty, osteotomies, shoulder arthroplasty, and knee arthroplasty. Patient-specific implant (PSI) technology aims to reduce overall procedural costs, maximize patient outcomes, and minimize surgical time by achieving better biomechanical implant fits.

Furthermore, the constant technological advancements, such as the use of imaging technologies such as computed tomography and magnetic resonance imaging (MRI) in patient-specific implants, are also driving the market growth. The rise of smart technologies has extended its reach toward dental implants, cranial implants, and others with innovative solutions aimed at improving post-implant monitoring. Innovations include smart implants that are fixed with sensors that provide real-time data on factors such as temperature and pressure.

  • For instance, in October 2023, 3D Systems launched a patient-specific 3D-printed cranial implant using the company’s point-of-care technologies successfully used in a cranioplasty at the University Hospital Basel (Switzerland).

In addition, the growing investments in research and development activities by the companies have further contributed to the market growth. Companies are continuously working toward innovation and the advancements of implant technologies.

  • For instance, in September 2019, Evonik Venture Capital invested in a 3D printing start-up in China, making implants for neuro and spine surgery. The technology enables faster patient recovery and reduces surgical risks. Moreover, the implants are 3D printed with high-quality polymers called Polyetheretherketone (PEEK), which Evonik supplies.

The COVID-19 pandemic negatively impacted the market due to disruptions in the global supply chains, which affected the availability of raw materials and components necessary for implant manufacturing. This led to temporary shortages and delays in product launches. Moreover, the pandemic led to a substantial disruption in elective surgeries, including patient-specific implants. Hospitals and healthcare facilities prioritized COVID-19 treatment, postponing non-urgent procedures to allocate resources and reduce the risk of transmission.

Segmentation

By Product

By Material

By Application

By End User

By Geography

  • Cranial Implants
  • Orthopedic Implants
  • Dental Implants
  • Others
  • Alloy
  • Polyetheretherketone (PEEK)
  • Polymethylmethacrylate (PMMA)
  • Poly-ether-ketone-ketone (PEKK)
  • Others
  • Neurosurgery
  • Trauma
  • Dental & Maxillofacial Surgery
  • Orthopedic Surgery
  • Others
  • Hospitals & ASCs
  • Specialty Clinics
  • Others
  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Key Insights

The report covers the following key insights:

  • Number of Key Procedures, By Key Countries, 2022/2023
  • Overview: Technological Advancements in Patient-Specific Implants
  • Key Industry Developments (Mergers, Acquisitions, and Partnerships)
  • Impact of COVID-19 on the Market
  • New Product Launches, By Key Players

Analysis by Product

By product, the market is segmented into cranial implants, orthopedic implants, dental implants, and others. The orthopedic implants segment accounted for a significant market share in 2023. The growth was mainly due to the increasing prevalence of orthopedic conditions such as osteoarthritis, rheumatoid arthritis, and traumatic injuries, which is increasing the need for surgical interventions. These patient-specific orthopedic implants are increasingly providing durable and effective solutions for joint replacements, spinal surgeries, and others, boosting their demand.

  • For instance, in April 2023, Zimmer Biomet was recognized for enhancing total hip replacement surgeries' efficiency, precision, and personalization. The company’s product ROSA HIP technology and ONE Planner Hip patient-specific acetabular and femoral mapping improve surgical delivery and outcomes.

Moreover, significant advancements in 3D printing and computer-aided design technologies have revolutionized the development of orthopedic implants, further augmenting segmental growth.

Furthermore, the cranial implants segment is projected to witness fast growth in the forecast period owing to the growing awareness among patients and healthcare providers regarding the benefits of advanced neurosurgical procedures that utilize patient-specific implants.

Moreover, these implants have shown significant potential in exhibiting enhanced recovery rates, owing to an increasing number of neurosurgeons adopting these technologies. Thus, the aforementioned factors will further contribute to the growing demand for cranial implants in the coming years.

Regional Analysis

To gain extensive insights into the market, Download for Customization

The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is projected to account for a significant share of the global patient-specific implants market. Advanced healthcare infrastructure and the presence of skilled healthcare providers enable the rapid integration of patient-specific implants into clinical practices, ensuring that patients have access to the latest available treatment options. Thus, constant technological advancements coupled with the growing focus on better treatment options are surging the adoption of these products in the region.

  • For instance, in April 2024, 3D Systems announced receiving the U.S. FDA authorization for its 3D printed, patient-specific cranial implant solution. The product is available in the U.S., which will further enhance the implant procedures in the country.

Asia Pacific is projected to witness the fastest growth rate in the coming years owing to the growing healthcare expenditure in the region coupled with an increasing focus on research and innovation toward the development of new implants by academic and research institutes. These new implants will assist healthcare providers in implementing and designing custom implants for patients to provide better treatment options. Thus, increasing research and development activities in countries such as China, India, and others contribute to market growth.

  • For instance, in December 2023, Zoriox Innovation Labs and researchers from the Indian Institute of Technology Madras developed 3D-printed face implants for patients suffering from Black Fungus.

Key Players Covered

The report includes the profiles of key players, such as Zimmer Biomet, Onkos, Materialise, Stryker, Johnson & Johnson Services, Inc., and 3D Systems, Inc.

Key Industry Developments

  • In February 2024, Materialise launched its personalized TMJ total Anthropology System, a solution to treat patients who require total temporomandibular joint (TMJ) arthroplasty. This new solution offers a personalized treatment for patients facing severe TMJ complications that require a joint replacement.
  • In December 2022, Enovis Corporation received the U.S. FDA approval for patient-specific instrumentation for the star total ankle replacement system. The instrument will benefit patients by offering personalized and accurate implant sizing to match their unique anatomy.
  • In July 2022, Onkos Surgical received the U.S. FDA authorization for its 3D printed, patient-specific pelvic reconstruction system. The company’s My3D Personalized Pelvic Reconstruction system includes 3D printed implants, models, instruments, and advanced planning services to treat trauma, disease, and deformity. 


  • Ongoing
  • 2024
  • 2019-2023
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann